marijuana stock news

OrganiGram Holdings Inc. (OGRMF)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Nov 30, 2014 Jul 31, 2014 Apr 30, 2014 Jan 31, 2014
Total Revenue 12   –   –   –  
Cost of Revenue 6
Gross Profit 6   –   –   –  
Operating Expenses
Research Development
Selling General and Administrative 723 177 24 12
Non Recurring 2 (11)
Others
Total Operating Expenses
Operating Income or Loss (718) (177) (26) (2)
Income from Continuing Operations
Total Other Income/Expenses Net 5
Earnings Before Interest And Taxes (718) (172) (25) (2)
Interest Expense
Income Before Tax (718) (172) (25) (2)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (718) (172) (25) (2)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (718) (172) (25) (2)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (718) (172) (25) (2)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Transcanna Holdings Inc. (TCAN) (TCAN.CN) Signs LOI with Persuasion Brewing Co. to Create CBD-Infused Non-Alcoholic Beer

TransCanna Signs LOI with Persuasion Brewing Co. to Create CBD-Infused Non-Alcoholic Beer…

$GRCU Announces Dr. Trent Jones as New CEO

Green Cures & Botanical Distribution Inc., announces changes to the Executive Team…

$INSY Beats 1Q Profit Forecasts

Insys Therapeutics beats 1Q profit forecasts Insys Therapeutics posts 1Q profit of…

GW Pharmaceuticals plc (GWPH) Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX®

GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol)…